Total lymphocyte counts and ART in resource-limited settings

Lancet

Volumn 366, Issue 9500, 2005, Pages 1831-1832

  Moore, David ^a,b   Montaner, Julio ^a  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD CELL COUNT; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MEDICAL RESEARCH; MORBIDITY; MORTALITY; NOTE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

EID: 28044454784     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67736-7     Document Type: Note

References (16)

1. N Kumarasamy Generic antiretroviral drugs - will they be the answer to HIV in the developing world? Lancet 364 2004 3 4
2. Martinson N, Heyer A, Steyn J, et al., Does WHO clinical stage reliably predict who should receive ARV treatment? Third International AIDS Society conference on HIV pathogenesis and treatment. Rio de Janeiro, Brazil, July 24-27 2005: WeFo0304 (abstr)
3. K Kober, W Van Damme Scaling up access to antiretroviral treatment in southern Africa: who will do the job? Lancet 364 2004 103 107
4. M Rabkin, W El-Sadr, DA Katzenstein Antiretroviral treatment in resource-poor settings: clinical research priorities Lancet 360 2002 1503 1505
5. N Kumarasamy, AP Mahajan, TP Flanigan Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries J Acquir Immune Defic Syndr 31 2002 378 383
6. M Badri, R Wood Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings AIDS 17 2003 541 545
7. MA Jacobson, L Liu, H Khayam-Bashi, SG Deeks, FM Hecht, J Kahn Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy AIDS 17 2003 917 919
8. NO Akinola, O Olasode, IA Adediran The search for a predictor of CD4 cell count continues: total lymphocyte count is not a substitute for CD4 cell count in the management of HIV-infected individuals in a resource-limited setting Clin Infect Dis 39 2004 579 581
9. G Liotta, CF Perno, S Ceffa Is total lymphocyte count a reliable predictor of the CD4 lymphocyte cell count in resource-limited settings? AIDS 18 2004 1082 1083
10. LA Spacek, M Griswold, TC Quinn, RD Moore Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings AIDS 17 2003 1311 1317
11. M Schechter, R Zajdenverg, LL Machado, ME Pinto, LA Lima, MA Perez Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system J Acquir Immune Defic Syndr Hum Retrovirol 7 1994 163 168
12. DT Dunn, DM Gibb, T Duong for the HIV Paediatric Prognostic Markers Collaborative Study group Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data Lancet 366 2005 1868 1874
13. R Bedell, KV Heath, RS Hogg Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings Antivir Ther 8 2003 379 384
14. RS Hogg, B Yip, KJ Chan Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy JAMA 286 2001 2568 2577
15. PK Kotylo, NS Fineberg, KS Freeman, NL Redmond, C Charland Reference ranges for lymphocyte subsets in pediatric patients Am J Clin Pathol 100 1993 111 115
16. ES Lugada, J Mermin, F Kaharuza Population-based hematologic and immunologic reference values for a healthy Ugandan population Clin Diagn Lab Immunol 11 2004 29 34